Women's Health Market Research Reports & Industry Analysis
Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.
Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.
Women's Health Industry Research & Market Reports
-
Artificial Insemination
... CAGR of 7.2% over the analysis period 2024-2030. Intrauterine Insemination, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More
-
Breast Lesion Localization
... at a CAGR of 4.5% over the analysis period 2024-2030. Breast Biopsy, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$309.2 Million by the end of ... Read More
-
Assisted Reproductive Technology
... at a CAGR of 4.9% over the analysis period 2024-2030. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$22.0 Billion by the end ... Read More
-
Breast Implants
... CAGR of 6.0% over the analysis period 2024-2030. Silicone Implants, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.2 Billion by the end of the analysis ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million ... Read More
-
Fertility Testing
... CAGR of 6.3% over the analysis period 2024-2030. Ovulation Predictor Kits, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$571.1 Million by the end of the ... Read More
-
Women`s Health Diagnostics
... at a CAGR of 5.8% over the analysis period 2024-2030. Breast Cancer Testing, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$11.3 Billion by the end ... Read More
-
Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2034
... of ~USD 25 Million in 2023. Among the seven major countries, the Postpartum Depression diagnosed prevalent cases were ~1,310,000, in 2023. In EU4 and the UK, the total Postpartum Depression diagnosed prevalent cases in Females ... Read More
-
Postpartum Depression - Pipeline Insight, 2025
... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Postpartum Depression: Understanding Postpartum Depression: ... Read More
-
Intrauterine Devices
... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Cervical Cancer Diagnostic Testing
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Testing, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More
-
Colposcopy
... 3.9% over the analysis period 2024-2030. Optical Instrument, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$580.3 Million by the end of the analysis period. Growth ... Read More
-
Online Sex Toys
... at a CAGR of 6.8% over the analysis period 2024-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.5 Billion by the end of ... Read More
-
Family Planning Centers
... at a CAGR of 3.3% over the analysis period 2024-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion by the end ... Read More
-
Uterine Cancer Therapeutics and Diagnostics
... Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Endometrial Carcinomas, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.0 Billion ... Read More
-
Ovulation Test
... CAGR of 4.0% over the analysis period 2024-2030. Urine, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More
-
Home Pregnancy Tests (HPT)
... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Digital Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$597.6 Million by the ... Read More
-
Breast Reconstruction
... CAGR of 5.5% over the analysis period 2024-2030. Breast Implants, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$629.5 Million by the end of the analysis ... Read More
-
Infertility Treatment
... CAGR of 7.5% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end of the analysis period. ... Read More
-
Breastfeeding Accessories
... CAGR of 6.6% over the analysis period 2024-2030. Breastmilk Storage & Feeding, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$974.4 Million by the end of ... Read More
-
Nursing Breast Pads
... at a CAGR of 5.9% over the analysis period 2024-2030. Reusable, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$220.4 Million by the end of the ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2025-2033
... 2025-2033. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women’s health through numerous campaigns and initiatives by the ... Read More
-
Vaginitis Therapeutics
... CAGR of 7.6% over the analysis period 2024-2030. Anti-Bacterial, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.7 Billion by the end of the analysis period. ... Read More
-
Endometriosis Drugs
... CAGR of 3.0% over the analysis period 2024-2030. Hormone therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More
-
Breast Biopsy Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$983.4 Million by the end ... Read More
Research Assistance
